LENSAR, Inc. (LNSR): Cost of Revenue
$31.31M
Year ended 2025-12-31
$31.13M
Trailing 12 months to 2026-06-30
+26.7%
3-year compound annual growth
+20.5%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $31.31M | +13.3% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $27.64M | +31.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $21.06M | +36.7% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $15.40M | -7.4% | 2024-03-04, From 2022-01-01 |
| 2021-12-31 | $16.63M | +35.1% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $12.31M | -28.9% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $17.30M | n/a | 2021-03-12, From 2019-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | 2025-12-31 | $31.31M | +13.3% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $8.31M | -0.3% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2025-12-31 | $42.63M | -33.0% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $19.80M | +5.6% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $12.47M | +75.2% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $12.79M | +40.7% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $11.12M | +52.6% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $6.96M | +69.8% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $10.70M | -7.6% |
Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗